Bolt Biotherapeutics, Inc. Depreciation
Bolt Biotherapeutics, Inc. (BOLT) reported Depreciation of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- Bolt Biotherapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $200.00K, a 33.33% decline year-over-year.
- Bolt Biotherapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $200.00K, a 50.00% decline year-over-year.
- Bolt Biotherapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $300.00K, a 25.00% decline year-over-year.
- Bolt Biotherapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $300.00K, a 40.00% decline year-over-year.
- Bolt Biotherapeutics, Inc. depreciation for fiscal 2025 was $1.30M, a 27.78% decline from fiscal 2024.
- Bolt Biotherapeutics, Inc. depreciation for fiscal 2024 was $1.80M, a 5.26% decline from fiscal 2023.
- Bolt Biotherapeutics, Inc. depreciation for fiscal 2023 was $1.90M, a 11.76% increase from fiscal 2022.
- Bolt Biotherapeutics, Inc. depreciation for fiscal 2022 was $1.70M, a 41.67% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-11 | $400.00K 10-Q · filed 2026-08-11 | $700.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.00M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-12 | $500.00K derived: sum of 2 quarters · filed 2026-05-12 | $800.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.10M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $600.00K derived: sum of 2 quarters · filed 2026-03-12 | $900.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.30M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $300.00K 10-Q · filed 2025-11-12 | $600.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.00M 10-Q · filed 2025-11-12 | $1.40M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-11 | $700.00K 10-Q · filed 2026-08-11 | $1.10M derived: sum of 3 quarters · filed 2026-08-11 | $1.60M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-12 | $800.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.30M derived: sum of 3 quarters · filed 2026-05-12 | $1.70M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $900.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.30M derived: sum of 3 quarters · filed 2026-03-12 | $1.80M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $500.00K 10-Q · filed 2025-11-12 | $900.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.40M 10-Q · filed 2025-11-12 | $3.20M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-14 | $900.00K 10-Q · filed 2025-08-14 | $2.70M derived: sum of 3 quarters · filed 2025-08-14 | $3.20M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $1.80M 10-Q · filed 2025-05-12 | $500.00K 10-Q · filed 2024-05-14 | $2.30M derived: sum of 2 quarters · filed 2025-05-12 | $2.80M derived: sum of 3 quarters · filed 2025-05-12 | $3.20M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.00M derived: sum of 2 quarters · filed 2025-03-24 | $1.40M derived: sum of 3 quarters · filed 2025-03-24 | $1.90M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $500.00K 10-Q · filed 2024-11-12 | $900.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.40M 10-Q · filed 2024-11-12 | $1.90M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $400.00K 10-Q · filed 2024-08-13 | $900.00K 10-Q · filed 2024-08-13 | $1.40M derived: sum of 3 quarters · filed 2024-08-13 | $1.80M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $500.00K 10-Q · filed 2024-05-14 | $1.00M derived: sum of 2 quarters · filed 2024-05-14 | $1.40M derived: sum of 3 quarters · filed 2024-05-14 | $1.80M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $900.00K derived: sum of 2 quarters · filed 2024-03-21 | $1.30M derived: sum of 3 quarters · filed 2024-03-21 | $1.70M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $400.00K 10-Q · filed 2023-11-09 | $800.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.20M 10-Q · filed 2023-11-09 | $1.60M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $400.00K 10-Q · filed 2023-08-07 | $800.00K 10-Q · filed 2023-08-07 | $1.20M derived: sum of 3 quarters · filed 2023-08-07 | $1.50M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-11 | $800.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.10M derived: sum of 3 quarters · filed 2023-05-11 | $1.30M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $700.00K derived: sum of 2 quarters · filed 2023-03-29 | $900.00K derived: sum of 3 quarters · filed 2023-03-29 | $1.20M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-10 | $500.00K derived: sum of 2 quarters · filed 2022-11-10 | $800.00K 10-Q · filed 2022-11-10 | $1.00M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-10 | $500.00K 10-Q · filed 2022-08-10 | $700.00K derived: sum of 3 quarters · filed 2022-08-10 | $900.00K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-12 | $500.00K derived: sum of 2 quarters · filed 2022-05-12 | $700.00K derived: sum of 3 quarters · filed 2022-05-12 | $800.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $400.00K derived: sum of 2 quarters · filed 2022-03-30 | $500.00K derived: sum of 3 quarters · filed 2022-03-30 | $600.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-09 | $300.00K derived: sum of 2 quarters · filed 2021-11-09 | $400.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-12 | $200.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |